Gamma-Knife-based stereotactic radiosurgery for uveal melanoma

Stereotactic and Functional Neurosurgery

Volumn 85, Issue 2-3, 2007, Pages 106-112

  Fakiris, Achilles J ^a,b   Lo, Simon S ^c,f   Henderson, Mark A ^a,b   Witt, Thomas C ^a,b   Worth, Robert M ^a,b   Danis, Ronald P ^d   Des Rosiers, Paul M ^a,b   Timmerman, Robert D ^e  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b Indiana Lions Gamma Knife Center   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f OHIO STATE UNIVERSITY   (United States)

Author keywords

Gamma Knife; Stereotactic radiosurgery; Uveal melanoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER PATIENT; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; HUMAN; MALE; METASTASIS; RADIATION DOSE; RISK ASSESSMENT; STATISTICAL ANALYSIS; STEREOTAXIC SURGERY; SURVIVAL RATE; TREATMENT OUTCOME; UVEA MELANOMA; VISUAL IMPAIRMENT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; RADIOSURGERY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UVEAL NEOPLASMS;

EID: 33947173895     PISSN: 10116125     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098525     Document Type: Article

References (18)

1. Inskip PD, Devesa SS, Fraumeni JF Jr: Trends in the incidence of ocular melanoma in the United States, 1974-1998. Cancer Causes Control 2003;14:251-257.
2. Strickland D, Lee JA: Melanomas of eye: stability of rates. Am J Epidemiol 1981;113:700-702.
3. Singh AD, Kivela T: The collaborative ocular melanoma study. Ophthalmol Clin North Am 2005;18:129-142, ix.
4. Gragoudas ES, Marie Lane A: Uveal melanoma: proton beam irradiation. Ophthalmol Clin North Am 2005;18:111-118, ix.
5. Rand RW, Khonsary A, Brown WJ, Winter J, Snow HD: Leksell stereotactic radiosurgery in the treatment of eye melanoma. Neurol Res 1987;9:142-146.
6. Cohen VM, Carter MJ, Kemeny A, Radatz M, Rennie IG: Metastasis-free survival following treatment for uveal melanoma with either stereotactic radiosurgery or enucleation. Acta Ophthalmol Scand 2003;81:383-388.
7. Langmann G, Pendl G, Klaus M, Papaefthymiou G, Guss H: Gamma knife radiosurgery for uveal melanomas: an 8-year experience. J Neurosurg 2000;93(suppl 3):184-188.
8. Marchini G, Gerosa M, Piovan E, Pasoli A, Babighian S, Rigotti M, Rossato M, Bonomi L: Gamma Knife stereotactic radiosurgery for uveal melanoma: clinical results after 2 years. Stereotact Funct Neurosurg 1996;66(suppl 1):208-213.
9. Mueller AJ, Talies S, Schaller UC, Horstmann G, Wowra B, Kampik A: Stereotactic radiosurgery of large uveal melanomas with the gamma-knife. Ophthalmology 2000;107:1381-1387.
10. Rennie I, Forster D, Kemeny A, Walton L, Kunkler I: The use of single fraction Leksell stereotactic radiosurgery in the treatment of uveal melanoma. Acta Ophthalmol Scand 1996;74:558-562.
11. Simonova G, Novotny J Jr, Liscak R, Pilbauer J: Leksell gamma knife treatment of uveal melanoma. J Neurosurg 2002;97:635-639.
12. Woodburn R, Danis R, Timmerman R, Witt T, Ciulla T, Worth R, Bank M, Coffman S: Preliminary experience in the treatment of choroidal melanoma with gamma knife radiosurgery. J Neurosurg 2000;93(suppl 3):177-179.
13. Zehetmayer M, Kitz K, Menapace R, Ertl A, Heinzl H, Ruhswurm I, Georgopoulos M, Dieckmann K, Potter R: Local tumor control and morbidity after one to three fractions of stereotactic external beam irradiation for uveal melanoma. Radiother Oncol 2000;55:135-144.
14. Langmann G, Pendl G, Mullner K, Feichtinger KH, Papaefthymiouaf G: High-compared with low-dose radiosurgery for uveal melanomas. J Neurosurg 2002;97:640-643.
15. Jampol LM, Moy CS, Murray TG, Reynolds SM, Albert DM, Schachat AP, Diddie KR, Engstrom RE Jr, Finger PT, Hovland KR, Joffe L, Olsen KR, Wells CG; Collaborative Ocular Melanoma Study Group (COMS Group): The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report No. 19. Ophthalmology 2002;109:2197-2206.
16. Melia BM, Abramson DH, Albert DM, Boldt HC, Earle JD, Hanson WF, Montague P, Moy CS, Schachat AP, Simpson ER, Straatsma BR, Vine AK, Weingeist TA; Collaborative Ocular Melanoma Study Group: Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years. COMS report No. 16. Ophthalmology 2001;108:348-366.
17. Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, Hawkins BS, Hayman JA, Jaiyesimi I, Jampol LM, Kirkwood JM, Koh WJ, Robertson DM, Shaw JM, Straatsma BR, Thoma J; Collaborative Ocular Melanoma Study Group: Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group report No. 26. Arch Ophthalmol 2005;123:1639-1643.
18. Georgopoulos M, Zehetmayer M, Ruhswurm I, Toma-Bstaendig S, Segur-Eltz N, Sacu S, Menapace R: Tumour regression of uveal melanoma after ruthenium-106 brachytherapy or stereotactic radiotherapy with gamma knife or linear accelerator. Ophthalmologica 2003;217:315-319.